Role of central and sympathetic nervous systems in pressor effect of L-NAME

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 1, 2003, Pages 68-72

  Huang, Fengyang ^a   Villafaña, Santiago ^a   Hong, Enrique ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Adrenal medulla; Central nervous system; Hypertension; L NAME; Nitric oxideSympathetic nervous system.

Indexed keywords

ADRENALIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORADRENALIN; RESERPINE;

ADRENAL MEDULLA; ADRENAL MEDULLECTOMY; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HYPERTENSION; INFUSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

ADRENAL MEDULLA; ANIMALS; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; MALE; NG-NITROARGININE METHYL ESTER; PRESSORECEPTORS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM;

EID: 0037215381     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200301000-00009     Document Type: Article

References (26)

1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature Lond 1980;288:373-6.
3. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
4. Moncada S, Higgs EA. Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991;21:956-60.
5. Nathan C. Nitric oxide as a secretory product mammalian cells. FASEB J 1992;6:3051-64.
6. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323: 27-36.
7. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990;347:768-70.
8. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 1995;57:683-706.
9. Moncada S. The L-arginine: Nitric oxide pathway. Acta Physiol Scand 1992;145:201-27.
10. Harada S, Tokunaga S, Momohara M, et al. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 1993;72:511-6.
11. Kagiyama S, Tsuchihashi T, Abe I, et al. Cardiovascular effects of nitric oxide in the rostral ventrolateral medulla of rats. Brain Res 1997;757:155-8.
12. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 1991;132:47-50.
13. Togashi H, Sakuma I, Yoshioka M, et al. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 1992;262:342-7.
14. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990;347:768.
15. Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension 1995;26:691-5.
16. Zanchi A, Schaad NC, Osterheld MC, et al. Effects of chronic NO synthase inhibition in rats on renninangiotensin system and sympathetic nervous system. Am J Physiol 1995;268:H2267-73.
17. Manning RD Jr, Hu L, Williamson TD. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition. Hypertension 1994;23:951-6.
18. 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am J Physiol 1994;266:R1470-6.
19. Tseng CJ, Liu HY, Lin HG, et al. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 1996;27:36-42.
20. Traystman RJ, Moore LE, Helfaer MA, et al. Nitro-Larginine analogues: Dose- and time-related nitric oxide synthase inhibition in brain. Stroke 1995;26:964-9.
21. Salter M, Duffy C, Garthwaite J, et al. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N-omega-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology 1995;34: 639-49.
22. Salter M, Duffy C, Hazelwood R. Determination of brain nitric oxide synthase inhibition in vivo: Ex vivo assays of nitric oxide synthase can give incorrect results. Neuropharmacology 1995;34:327-34.
23. Iadecola C, Xu X, Zhang F, et al. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res 1994;19:501-5.
24. Micalizzi ER, Pals DT. Evaluation of plasma norepinephrine as an index of sympathetic neuron function in the conscious, unrestrained rat. Life Sci 1979;24:2071-6.
25. Neff N, Nagi S, Wang T, et al. Calculation of the rate of catecholamine synthesis from the rate of conversion of tyrosine-14C to catecholamines. Mol Pharmacol 1969;5: 90-9.
26. Vollmer RR, Meyers-Schoy SA, Kolibal-Pegher SS, et al. The role of the adrenal medulla in neural control of blood pressure in rats. Clin Exper Hypertension 1995;17:649-67.